ORYZF OTC
Oryzon Genomics S.A.
1W: -6.3%
1M: -5.2%
3M: -15.1%
YTD: -7.7%
1Y: -8.3%
$3.10
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$13M
Revenue
+12.6% YoY
$-3M
Net Income
+11.5% YoY
$-8M
Free Cash Flow
+46.1% YoY
97.6%
Gross Margin
-20.1%
Op. Margin
-1.6%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-3.0%
ROA-2.5%
ROIC-7.2%
Valuation
P/E-87.6
P/B1.8
EV/EBITDA0.0
Leverage
Debt/Equity0.05
Current Ratio1.60
Interest Cov.-15.0x
Quality Scores
Piotroski F4/9
Altman Z—
Beneish M-1.65